Criticizing the Critics

Your article about British science1 misrepresented our Joint Code of Practice for Research. Far from wishing to "regulate" scientists or drown them in red tape, the Code of Practice is a significant and straightforward way in which we are striving to rebuild public confidence in science. We believe it is in everyone's interest that we ensure the highest quality standards in UK research.The criticisms in the article would perhaps be fair if, as the article suggests, our Code of Practice was a com

Written byHoward Dalton
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Your article about British science1 misrepresented our Joint Code of Practice for Research. Far from wishing to "regulate" scientists or drown them in red tape, the Code of Practice is a significant and straightforward way in which we are striving to rebuild public confidence in science. We believe it is in everyone's interest that we ensure the highest quality standards in UK research.

The criticisms in the article would perhaps be fair if, as the article suggests, our Code of Practice was a complicated set of paperwork "dreamed up" by a civil servant. This is not the case. The code has been developed by qualified and experienced scientists employed by the Civil Service and Research Councils, in discussion with scientists in research institutes. In reality, the Code of Practice simply provides a more overt framework for procedures that most researchers should already have in place: that managers ensure a climate ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies